Phase IV occurs post-approval, tracking the drug's long-term effects in the general population. Agonists bind to receptors and activate them, mimicking the action of endogenous substances, while antagonists block these sites, preventing natural ligands from binding.
Drug Development Approval Path: From Discovery to Post-Market Surveillance
Drugs and pharmacology represent the intricate science of how chemical substances interact with living organisms to produce changes in physiological or psychological function. High-throughput screening then tests thousands of compounds to identify "hits" that interact with the target.
Common categories include anti-infectives, cardiovascular agents, central nervous system modulators, and antineoplastics. Enzyme inhibitors reduce the activity of catalytic proteins, altering metabolic pathways, and ion channel modulators can change the flow of ions across cell membranes, thereby influencing neuronal excitability and muscle contraction.
Drug Development Approval Path: From Discovery to Post-Market Surveillance
Pharmacodynamics describes what a drug does to the body, focusing on its biochemical and physiological effects, including mechanisms of action and the relationship between drug concentration and effect. It typically begins with basic research, where scientists identify biological targets involved in disease pathways.
More About Drugs and pharmacology
Looking at Drugs and pharmacology from another angle can help expand the discussion and give readers a second clear paragraph under the same section.
More perspective on Drugs and pharmacology can make the topic easier to follow by connecting earlier points with a few simple takeaways.
